Connect Biopharma Holdings Ltd

Annual Trend FY 2012 FY 2013 FY 2014 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($1.0m) ($19k) $228k ($5.9b) ($5.8m) ($62.1m) ($15.6m) ($55.5m) ($64.6m)
Net loss from continuing operations ($5.8m) ($4.9m)
Purchase of financial assets at fair value through profit or loss ($163.0m) ($106.6m) ($114.5m) ($41.0m) ($1.6m)
Proceeds from disposal of financial assets at fair value through profit or loss $160.7m $124.8m $128.0m $41.1m $1.6m
Profit or Loss ($779.2m) ($205.0m) ($114.4m) ($59.5m)
Depreciation, Depletion and Amortization $627k $979k $660k $704k $695k
Depreciation Expense $5k $54k $39k $695k
Amortization Cash Flow $7k $9k
Amortization Of Intangibles $7k $9k $9k
Amortization Of Securities ($1.7m) ($123k) ($773k) ($531k)
Depreciation Amortization Depletion $720k $660k $704k $695k
Share-based Payment Arrangement, Noncash Expense $6.7m $3.7m $4.0m
Adjustments For Share-Based Payments $25.2m $57.9m $45.6m $3.3m
Share-based Payment Arrangement, Expense $6.7m $3.7m $4.0m
Stock-Based Compensation Expense $42k $0 $308k $4.0m
Asset Impairment Charge $0 $232k $0 $0
Other Nonoperating Income (Expense) $2.6m $523k
Nonoperating Income (Expense) $7.0m $2.8m
Changes in operating assets and liabilities:
Change In Working Capital $9.9m ($15.5m) $580k $3.2m
Increase (Decrease) in Accounts Receivable $789k ($776k) $8k
Accounts receivable ($266k) ($1.0m) $941k $8k
Change In Receivables $0 ($789k) $776k $8k
Changes In Account Receivables $0 ($789k) $776k $8k
Inventories ($249k) ($349k) $463k
Increase (Decrease) in Accounts Payable ($1.9m) $1.6m $3.5m
Accrued expenses and other payables $491k $66k ($188k)
Accounts payable - related party $3k ($3k) $10k $3.5m
Accounts payable and accrued liabilities ($136k) $11k ($12k) $3.5m
Change In Payables And Accrued Expense ($7.2m) ($3.5m) $5.0m $3.5m
Change In Accrued Expense ($6.1m) ($1.7m) $3.4m $3.5m
Change In Other Current Assets ($1.4m) $120k $120k
Change In Other Current Liabilities ($182k) $227k ($518k) ($542k)
Net Cash Provided by (Used in) Operating Activities ($1.0m)
($209) +99.98%
$237k +113670.81%
($90.3m) -38124.46%
($167.2m) -85.21%
($544.9m) -225.99%
($679.7m) -24.73%
($47.9m) +92.95%
($23.6m) +50.74%
($51.2m) -116.86%
($57.3m) -11.81%
Cash flows from investing activities:
Gain (Loss) on Disposition of Property Plant Equipment ($9k) ($37k) $37k
Cash paid for equipment, net cash received for sale or disposal ($211k) ($16k) ($311k)
Write-down of mineral property $100k $0
Payments to Acquire Property, Plant, and Equipment ($1.1m) ($15.0m) ($24.9m) ($29.3m) ($294k) $750k $434k ($434k)
Debt Securities, Available-for-sale, Realized Gain (Loss) $0 $0
Gain on sale of marketable securities ($198k) ($24k)
Proceeds from Investments $263k $184k $44.7m
Change in investments $19 $0
Cash, Cash Equivalents, and Short-term Investments $93.7m $44.3m
Net cash (used in)/generated from investing activities ($3.3m) $2.9m ($34.0m) ($571.3m) $75.2m
Net Cash from Investing Activities $436k $125k $152k ($697k) ($1.1m) $1.2m
Net Cash Provided by (Used in) Investing Activities ($3.5m) $9.8m $36.5m
Cash flows from financing activities:
Net Issuance Payments Of Debt ($126k) ($290k) ($290k)
Net Long Term Debt Issuance ($126k) ($290k) ($290k)
Long Term Debt Payments ($126k) ($290k) ($290k)
Repayment Of Debt ($126k) ($290k) ($290k)
Issuance Of Capital Stock $220.0m $44k $44k
Repurchase Of Capital Stock ($566k) $0 $0 $0
Common Stock Issuance $220.0m $44k $44k
Net Common Stock Issuance $219.4m $44k $44k
Common Stock Payments ($566k) $0 $0 $0
Net cash generated from/(used in) financing activities ($396k)
$918.8m +232110.35%
$1.3b +43.25%
($625k) -100.05%
($246k) +60.64%
Net Cash from Financing Activities $34k
$0 -100.00%
$9.1m
$4.1m -55.26%
$447k -89.05%
Net Cash Provided by (Used in) Financing Activities $227k
$1.1m +381.50%
$18.7m +1612.08%
Net increase/(decrease) in cash and cash equivalents ($94.0m) $754.5m $737.1m ($1.3b) $27.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($27.4m) ($39.9m) $45.6m
Cash, beginning of period $569k $12k $81k
Beginning Cash Position $78.9m $105.7m $78.2m $47.7m
Cash and cash equivalents at the beginning of year $309.0m $1.0b $1.7b $550.3m $106.0m
Cash and cash equivalents - beginning of period $7.2m $585k
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($595k) $408k $405k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78.2m $38.3m $45.6m
Effects of exchange rate changes on cash and cash equivalents $1.4m ($53.4m) ($40.3m) $95.0m $18k
Net effect of exchange rate changes on cash ($70k) ($1.1m) ($293k)
Effect of Exchange Rate on Cash $209 $2k $405k
Effect Of Exchange Rate Changes ($568k) ($595k) $408k $405k
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Gain (Loss) on Disposition of Intangible Assets $0
Income Tax Expense (Benefit) $223k $197k
Operating Lease, Expense $300k $500k
Interest Expense $0 $0 $3k $4k $9k
Income Tax Expense $42k $24k
Additional Financial Items
Proceeds from Stock Options Exercised $194k $875k
Adjustments For Increase Decrease In Trade Account Payable $1.9m $56.6m $2.6m ($4.3m)
Adjustments For Unrealised Foreign Exchange Losses Gains $6.8m $3.3m ($9.6m) ($367k)
General and Administrative Expense $19.2m $20.3m
Operating Expenses $48.5m $58.1m
Payments Of Lease Liabilities Classified As Financing Activities $538k $126k $218k $290k
Payments To Acquire Or Redeem Entitys Shares $576k $0
Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets $124.8m $20.1m $5.9m $1.6m
Purchase Of Intangible Assets Classified As Investing Activities $349k $48k $0
Cash used in operations ($90.3m) ($167.2m) ($544.9m) ($679.7m) ($47.9m)
Purchase of financial assets at fair value through other comprehensive income $0 ($737.5m) ($31.0m)
Proceeds from disposal of fixed assets, intangible assets and other long-term assets $0 $0 $2.9m
Proceeds from maturities of financial assets at fair value through other comprehensive income $0 $195.4m $103.6m
Payment of investment management fee $0 $0 ($84k)
Payment for right-of-use assets ($22.3m) $0 $0
Purchase of intangible assets ($349k) ($304k) $0 $0
Proceeds from exercise of options $49k $243k $758k $0
Proceeds from issuance of ordinary shares $1.4b $132k $44k
Payment for lease liabilities ($445k) ($538k) ($805k) ($1.5m) ($290k)
Payment for repurchase of ordinary shares ($3.7m) $0 $0
Payment in relation to listing expenses ($1.1m) ($111.4m) $0 $0
Advance payments and prepaid expenses ($49k) ($1.3m) ($721k)
Security deposits ($19k) ($133k) $9k
Income tax payable $4k $20k ($24k)
Disposal of construction in progress ($169k) ($113k) $282k
Disposal of land and improvements ($1.1m) $1.1m
Cash paid for stock ($317k) $129k
Expenses contributed to capital $20k ($5k) $87k
Common shares sold $3.9m $205k
Loans and other long term liabilities $272k $27k
Stock issuance $9.1m ($52k)
Net Change in Cash ($557k) ($11k) $81k
Imputation of interest on shareholder loans $4k $8k
Expenses paid by shareholders $4k $5k
Prepaid expenses and deposits $18k $18k ($7k)
Gain on reversal of income tax penalty accrual $0 ($250k)
Gain on deconsolidation $0
Equity loss pick-up $0
Imputed interest on loan from related party $13k $25k
Value of services provided by officer $0 $12k
Loss on amounts due to related party $0
Nubian option agreement $128k $0
Due from affiliate $17k $0
Proceeds from Stock Issuance $34k $0
Shares issued for the settlement of amounts due to related parties $0
Change in notes payable $0
Cash Flow From Continuing Financing Activities $45k $227k $1.1m $18.7m
Cash Flow From Continuing Investing Activities $75.0m ($3.5m) $9.8m $36.5m
Change In Account Payable ($1.1m) ($1.9m) $1.6m $3.5m
Change In Other Working Capital $13.6m ($13.2m) ($548k) ($548k)
Change In Payable ($1.1m) ($1.9m) $1.6m $3.5m
Change In Prepaid Assets $3.7m $1.8m ($4.1m) ($2.6m)
Changes In Cash $27.3m ($26.8m) ($40.3m) ($2.1m)
End Cash Position $105.7m $78.2m $38.3m $45.6m
Financing Cash Flow $45k
$227k +404.44%
$1.1m +381.50%
$18.7m +1612.08%
Free Cash Flow ($47.8m) ($24.4m) ($51.6m) ($57.6m)
Gain Loss On Investment Securities ($68k) ($1k) ($5k)
Gain Loss On Sale Of PPE $102k $9k $37k $3k
Investing Cash Flow $75.0m ($3.5m) $9.8m $36.5m
Net Foreign Currency Exchange Gain Loss $516k ($367k) ($367k)
Net Intangibles Purchase And Sale ($48k) $0 $0 $0
Net PPE Purchase And Sale $2.9m ($750k) ($432k) ($353k)
Operating Gains Losses $101k $9k $37k $37k
Other Non Cash Items $7k ($2.0m)
Proceeds From Stock Option Exercised $45k $227k $1.1m $1.2m
Purchase Of Intangibles ($48k) $0 $0 $0
Purchase Of PPE $3.9m $4.2m ($81k) ($750k) ($434k) ($434k)
Sale Of PPE $2.9m $0 $2k $0
Stock Based Compensation $5.4m $6.7m $3.7m $4.0m
Unrealized Gain Loss On Investment Securities $104.0m $0 $0 $0
Net Investment Purchase And Sale $72.1m ($2.7m) $10.2m $36.8m
Purchase Of Investment ($31.0m) ($15.5m) ($30.5m) ($7.9m)
Sale Of Investment $103.1m $12.8m $40.7m $44.7m
Net Change in Cash and Cash Equivalents $7.2m ($6.6m) ($293k)
Cash and cash equivalents - end of period $7.2m $620k $292k
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported $26.7m ($27.4m) ($39.9m)
Income Taxes Paid, Net $0 $0 $120k $111k $292k

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.